We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SY
3576
So-Young International
SY
$219M
$5.5K ﹤0.01%
5,345
+735
+16% +$1.03K
PBYI icon
3577
Puma Biotechnology
PBYI
$454M
$5.49K ﹤0.01%
2,086
VSTM icon
3578
Verastem
VSTM
$610M
$5.48K ﹤0.01%
674
DAC icon
3579
Danaos Corp
DAC
$2.56B
$5.43K ﹤0.01%
+82
New +$5.51K
AOUT icon
3580
American Outdoor Brands
AOUT
$157M
$5.38K ﹤0.01%
550
YJ
3581
Yunji
YJ
$16.7M
$5.34K ﹤0.01%
1,937
WNEB icon
3582
Western New England Bancorp
WNEB
$275M
$5.33K ﹤0.01%
822
ML
3583
DELISTED
MoneyLion Inc.
ML
$5.32K ﹤0.01%
245
-633
-72% -$10.5K
JG
3584
Aurora Mobile
JG
$29.8M
$5.28K ﹤0.01%
1,955
+1,525
+355% +$6.4K
FENG
3585
Phoenix New Media
FENG
$18M
$5.26K ﹤0.01%
4,176
CMRX
3586
DELISTED
Chimerix, Inc.
CMRX
$5.17K ﹤0.01%
5,391
-5,744
-52% -$6.25K
HNST icon
3587
The Honest Company
HNST
$586M
$5.09K ﹤0.01%
4,040
-4,105
-50% -$6.01K
AMBO
3588
Ambow Education Holding
AMBO
$5.15M
$4.98K ﹤0.01%
2,785
NBP
3589
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$4.98K ﹤0.01%
3,776
ZDGE icon
3590
Zedge
ZDGE
$38.9M
$4.98K ﹤0.01%
2,273
CMPS
3591
Compass Pathways
CMPS
$1.83B
$4.88K ﹤0.01%
660
+75
+13% +$664
YDKG
3592
Yueda Digital Holding
YDKG
$5.97M
$4.81K ﹤0.01%
46
ORMP icon
3593
Oramed Pharmaceuticals
ORMP
$179M
$4.78K ﹤0.01%
1,830
CLLS
3594
Cellectis
CLLS
$285M
$4.69K ﹤0.01%
2,970
RNW icon
3595
ReNew
RNW
$2.25B
$4.69K ﹤0.01%
864
-1,600
-65% -$9.44K
MREO
3596
Mereo BioPharma
MREO
$47.3M
$4.64K ﹤0.01%
3,598
+340
+10% +$451
VYX icon
3597
NCR Voyix
VYX
$1.14B
$4.63K ﹤0.01%
456
-748,125
-100% -$12.7M
GAIA icon
3598
Gaia
GAIA
$48.4M
$4.62K ﹤0.01%
1,700
SGC icon
3599
Superior Group of Companies
SGC
$225M
$4.59K ﹤0.01%
590
-785
-57% -$6.81K
FONR
3600
DELISTED
Fonar
FONR
$4.59K ﹤0.01%
298

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.